We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Saliva: New Diagnostic Alternative to Blood?

By Labmedica staff writers
Posted on 01 Apr 2008
Print article
Image: Light micrograph of human saliva (Photo courtesy of CMSP).
Image: Light micrograph of human saliva (Photo courtesy of CMSP).
Scientists have succeeded in identifying all the 1,166 proteins in human ductal saliva. The study of proteomics and genomics of saliva are part of a U.S. effort to create the first map of every human protein and every protein interaction, because they contribute to health and disease and act as markers for disease states. Defining exact protein pathways on a comprehensive scale will enable the development of early diagnostic testing and precise drug design. Following instructions encoded by genes, protein "machines” make up the body's organs and regulate its cellular processes.

The term saliva is increasingly reserved by scientists only for the salivary gland secretions (ductal saliva). This new definition is significant because of the emerging theory that the mix of proteins in ductal saliva tracks closely with that of blood, making saliva a potential diagnostic stand-in for blood.

The saliva of 23 adults, which included men and women of various racial backgrounds, was tested by scientists from across the United States. Although the sample size was small, the findings could lead to future study of people who are healthy and those who suffer from any one of a variety of illnesses.

To construct a credible protein list for saliva, three teams of scientists used competing techniques both to capture the greatest number of protein candidates for the list and to lend extra credibility to those found using different methodologies. Each team subjected saliva collected from patients to some form of mass spectrometry, which determined the identity of proteins based on measurements of their mass and charge.

The teams succeeded in identifying the entire proteome in parotid and submandibular/sublingual saliva. The results indicated that more than one-third of saliva proteins were found in the blood proteome as well. Comparison of these proteins against known protein pathways and other proteomes provided a first glimpse of the function of the core proteins. A number of the salivary proteins were found to match proteins with known roles in Alzheimer's, Huntington's, and Parkinson's diseases; breast, colorectal, and pancreatic cancer; and type I and II diabetes. Specifically, most of the proteins were found to be part of signaling pathways, which is central to the body's response to (and therefore diagnostic of) system-wide diseases. These findings were reported online in the March 25, 2008, issue of the Journal of Proteome Research.

Determining the salivary proteome is only the first step toward salivary-based diagnosis and treatment. The protein information is already being incorporated into microarray technology, a high-speed test that can determine the levels of multiple proteins during disease progression. Related work is underway under within the National Institutes of Health (NIH; Bethesda, MD, USA)-funded Bioengineering Nanotechnology Initiative to design biochips, nanoscale computer chips packed with salivary protein chains. Protein probes on the chip react with proteins in a saliva sample, for instance, from the mouth of someone with oral cancer, and inform a computer about which proteins are present.

The U.S. National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, funded the current study. The saliva proteome study represents a consortium effort with scientists at The Scripps Research Institute (La Jolla, CA, USA), University of Rochester (Rochester, NY, USA), University of Southern California (Los Angeles, CA, USA), University of California at San Francisco (San Francisco, CA, USA), and University of California at Los Angeles (Los Angeles, CA, USA).

James E. Melvin, D.D.S., Ph.D., director of the Center for Oral Biology at the University of Rochester Medical Center (Rochester, NY, USA), said, "Our work, and the work of our partners, has shown that salivary proteins may represent new tools for tracking disease throughout the body--tools that are potentially easier to monitor in saliva than in blood.”


Related Links:
The Scripps Research Institute
National Institutes of Health
University of Rochester
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Unit-Dose Packaging solution
HLX
New
Four-in-One Desktop Testing Solution
GULP-1sim/GULP-1ble
New
Automated Nucleic Acid Extraction Instrument
EX9600

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.